Á¦14ȸ ´ëÇѼö¸éÇÐȸ Á¤±âÇмú´ëȸ I : 2019-12-07
±³À°ÀÏÀÚ : 2019-12-07
±³À°Àå¼Ò : ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ ¿Ü
±³À°ÁÖÁ¦ : Á¦14ȸ ´ëÇѼö¸éÇÐȸ Á¤±âÇмú´ëȸ I
ÁÖÃÖ±â°ü : ´ëÇÑÀ̺ñÀÎÈÄ°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѼö¸éÇÐȸ
´ã´çÀÚ : ´ëÇѼö¸éÇÐȸ
¿¬¶ôó : 02-3487-9091
À̸ÞÀÏ : entsoc@korl.or.kr
±³À°Á¾·ù : ÀÇ»çÇÐ
Âü¼®¿¹»óÀοø : 400¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 20 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 50,000¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 12-07 ÄÁº¥¼ÇȦ 08:30~09:00 DDx.on sleep breathing disorder ½ÅÀ¯¿ë(³ªÀºº´¿ø)
±³À°½Ã°£ 12-07 ÄÁº¥¼ÇȦ 09:00~09:30 DDx.on parasomnia Ȳ°æÁø(°æÈñÀÇ´ë)
±âŸ 12-07 ÄÁº¥¼ÇȦ 09:30~09:50 opening À±Àοµ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 12-07 ÄÁº¥¼ÇȦ 09:50~10:30 The role of sleep in fear processes underlying PTSD and Anxiety disorders Sean Drummond(Monash univ.)
±³À°½Ã°£ 12-07 ÄÁº¥¼ÇȦ 10:30~11:10 µðÁöÅÐ ÇコÄɾî, ÀÇ·áÀÇ ¹Ì·¡: ¼ö¸éÀ» Áß½ÉÀ¸·Î ÃÖÀ±¼·(µðÁöÅÐ ÇコÄɾ±¸¼Ò)
ÈÞ½Ä 12-07 11:10~11:20 coffee break ()
±³À°½Ã°£ 12-07 ÄÁº¥¼ÇȦ 11:20~11:45 non-visual effect of light on sleep and cognition in dementia ÀÌÁ¤Èñ(°¿øÀÇ´ë)
±³À°½Ã°£ 12-07 ÄÁº¥¼ÇȦ 11:45~12:10 visual impact of light on alertness and cognition ±èÅÂ(GIST)
±³À°½Ã°£ 12-07 ÄÁº¥¼ÇȦ 12:10~12:35 activity rhythm and light exposure in insomnia disorder ±è¼ºÀç(µµÀºº´¿ø)
±³À°½Ã°£ 12-07 ÄÁº¥¼ÇȦ-1 12:40~13:10 machine effect Á¶À翵(¼¿ïÀÇ´ë)
±³À°½Ã°£ 12-07 ÄÁº¥¼ÇȦ-1 13:10~13:40 patient effect ±èÈ¿¿(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 12-07 ÄÁº¥¼ÇȦ-1 13:50~14:15 management of central sleep apnea syndrome ¾ç±¤ÀÍ/±è»óÇÏ/±è¼¼¿ø(¼øõÇâÀÇ´ë/¿øÁÖÀÇ´ë/°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 12-07 ÄÁº¥¼ÇȦ-1 14:15~14:40 management of sleep-related hypoventilation disorder ±è»óÇÏ(¿øÁÖÀÇ´ë)
±³À°½Ã°£ 12-07 ÄÁº¥¼ÇȦ-1 14:40~15:05 management of patients with sleep related hypoxemia disorder ±è¼¼¿ø(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 12-07 ÄÁº¥¼ÇȦ-1 12:40~13:10 pap therapy in mild to moderate OSA ±èÈÄ¿ø(Á¶¼±ÀÇ´ë)
±³À°½Ã°£ 12-07 ÄÁº¥¼ÇȦ-1 13:10~13:40 oral appliance in mild to moderate OSA ±è°æ¾Æ(°æÈñÄ¡´ë)
±³À°½Ã°£ 12-07 ÄÁº¥¼ÇȦ-2 13:50~14:15 wearable device for measuring of sleep quantity and quality ±èÁ¤ÈÆ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 12-07 ÄÁº¥¼ÇȦ-2 14:15~14:40 validation of fitbit for sleep tracker in osa º¯Á¤ÀÍ(°æÈñÀÇ´ë)
±³À°½Ã°£ 12-07 ÄÁº¥¼ÇȦ-2 14:40~15:05 validation and utility of a consumer sleep tracker in insomnia sean drummond(Monash univ.)
ÈÞ½Ä 12-07 15:05~15:20 coffee break ()
±³À°½Ã°£ 12-07 ÄÁº¥¼ÇȦ-2 15:20~15:45 neural circuitry for Rem genesis ÁÖº´¾ï(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 12-07 ÄÁº¥¼ÇȦ-2 15:45~16:10 rem sleep and memory ¾öÀ¯Çö(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 12-07 ÄÁº¥¼ÇȦ-2 16:10~16:35 rem atonia, cataplexy, and RBD ÀÌÈ£¿ø(°æºÏÀÇ´ë)
±³À°½Ã°£ 12-07 ÄÁº¥¼ÇȦ-2 16:35~16:55 delated sleep phase syndrome in children and adolescents À¯ÈñÁØ(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 12-07 ÄÁº¥¼ÇȦ-2 16:55~17:15 narcolepsy in children and adolescents ±è½Â¼ö(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 12-07 ÄÁº¥¼ÇȦ-2 17:15~17:35 sleep related breathing disorder in children and adolescents ¹Úµµ¾ç(¾ÆÁÖÀÇ´ë)
±³À°½Ã°£ 12-07 ÄÁº¥¼ÇȦ-2 17:35~17:55 insomnia in children and adolescents À̼±°æ(Â÷ÀÇ´ë)
±âŸ 12-07 ÄÁº¥¼ÇȦ-1 15:20~15:35 RESMED ÀÌÇý¸²()
±âŸ 12-07 ÄÁº¥¼ÇȦ-1 15:35~15:50 PHILIPS È«Á¾¼®()
±âŸ 12-07 ÄÁº¥¼ÇȦ-1 15:50~16:05 VitalAire ÀÌ¿©±Ç()
±âŸ 12-07 ÄÁº¥¼ÇȦ-1 16:05~16:20 YuYu Teijin õ°æ½Ä()
±âŸ 12-07 ÄÁº¥¼ÇȦ-1 16:20~16:35 Panel discussion ÃÖÁöÈ£/±è»óÇÏ/±èÈÄ¿ø(¼øõÇâÀÇ´ë/¿øÁÖÀÇ´ë/Á¶¼±ÀÇ´ë)
±âŸ 12-07 ÄÁº¥¼ÇȦ 16:35~17:50 Á¤Ã¥Æ÷·³ À±Àοµ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 12-07 ´ëȸÀÇ½Ç 08:30~08:50 questionnares for insomnia ÀüÈ«ÁØ(°Ç±¹ÀÇ´ë)
±³À°½Ã°£ 12-07 ´ëȸÀÇ½Ç 08:50~09:10 questionnares for hypersomnia ÀüÁö¿¹(°æºÏÀÇ´ë)
±³À°½Ã°£ 12-07 ´ëȸÀÇ½Ç 09:10~09:30 questionnaires for circadian rhythm disorder °¹Ì¸®(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 12-07 ´ëȸÀÇ½Ç 11:20~11:40 homeostatic mechanism in sleep regulation ±èÁö¿µ(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 12-07 ´ëȸÀÇ½Ç 11:40~12:00 sleepapnea:mechanism and complications Á¶±ÔÈ£(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 12-07 ´ëȸÀÇ½Ç 12:00~12:20 PAP therapy in OSA ±è»óÇÏ(¿øÁÖÀÇ´ë)
±³À°½Ã°£ 12-07 ´ëȸÀÇ½Ç 12:20~12:40 Insomnia : mechanism and management ÁÖ°¡¿ø(ÃæºÏÀÇ´ë)
±³À°½Ã°£ 12-07 ´ëȸÀÇ½Ç 12:40~13:10 Esezolpiclone Á¤¼®ÈÆ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 12-07 ´ëȸÀÇ½Ç 13:10~13:40 Orexin antagnoist ÇѼ±Á¤(¿ø±¤ÀÇ´ë)
±³À°½Ã°£ 12-07 ´ëȸÀÇ½Ç 13:50~14:15 Hypersonmia current concepts ±èÅÂÁØ(¾ÆÁÖÀÇ´ë)
±³À°½Ã°£ 12-07 ´ëȸÀÇ½Ç 14:15~14:40 circadian rhythm disorder ¼ÛÆĸá¶ó(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 12-07 ´ëȸÀÇ½Ç 14:40~15:05 parasomnia Á¤À¯Áø(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 12-07 ´ëȸÀÇ½Ç 15:20~16:35 sleep staging, arousal, respiratory events, movement events ±èÇýÀ±/°íÅ°æ/ÀÌÁöÇö(°¡Å縯°üµ¿ÀÇ´ë/ºÎ»ê¼º¸ðº´¿ø/µå¸²¼ö¸éÀÇ¿ø)
±³À°½Ã°£ 12-07 ±³À°Àå2 11:20~11:40 Çѱ¹ÆÇ ºÒ¸éÁõ ÀÓ»óÁø·áÁöħ 2019 °³¹ß ¹× ÁÖ¿ä ±Ç°í»çÇ× Á¤¼®ÈÆ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 12-07 ±³À°Àå2 11:40~12:00 ºÒ¸éÁõÀÇ Áø´Ü È帧¿¡ µû¸¥ °Ë»ç ¹× Ä¡·á ÃÖÇÏ¿¬(º¸Èƺ´¿ø)
±³À°½Ã°£ 12-07 ±³À°Àå2 12:00~12:20 ºÒ¸éÁõÀÇ ÀÎÁöÇൿġ·á ÀÌÁöÇö(µå¸²¼ö¸éÀÇ¿ø)
±³À°½Ã°£ 12-07 ±³À°Àå2 12:20~12:40 ºÒ¸éÁõÀÇ ¾à¹°Ä¡·á ±èÁöÇö(´Ü±¹ÀÇ´ë)
±³À°½Ã°£ 12-07 ±³À°Àå2 13:50~14:15 prevention and treatment of augmentation in RLS ¹æ¿µ·Õ(µ¿¾ÆÀÇ´ë)
±³À°½Ã°£ 12-07 ±³À°Àå2 14:15~14:40 alpha-2delta ligands and other medication ¾çÅ¿ø(°æ»óÀÇ´ë)
±³À°½Ã°£ 12-07 ±³À°Àå2 14:40~15:05 iron therapy in RLS ±è±ÙÅÂ(°è¸íÀÇ´ë)
±³À°½Ã°£ 12-07 ±³À°Àå2 15:20~15:45 medication ÀÌÁ¤¼®(¸¼Àº»ùÁ¤½Å°Ç°ÀÇÇаú)
±³À°½Ã°£ 12-07 ±³À°Àå2 15:45~16:10 alcohol ½ÅÇö¿ì(¼¿ïÀÇ´ë)
±³À°½Ã°£ 12-07 ±³À°Àå2 16:10~16:35 sleep deprivation ÇѼöÇö(Áß¾ÓÀÇ´ë)